$PMDI
PSYCHEMEDICS CORP

2021 Q1 Form 10-Q Financial Statement

#000117184321003502 Filed on May 13, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q1
Revenue $5.713M $7.537M
YoY Change -24.2% -23.26%
Cost Of Revenue $3.145M $4.809M
YoY Change -34.6% -11.17%
Gross Profit $2.568M $2.728M
YoY Change -5.87% -38.11%
Gross Profit Margin 44.95% 36.19%
Selling, General & Admin $2.171M $2.639M
YoY Change -17.73% -13.3%
% of Gross Profit 84.54% 96.74%
Research & Development $280.0K $331.0K
YoY Change -15.41% -21.19%
% of Gross Profit 10.9% 12.13%
Depreciation & Amortization $690.0K $610.0K
YoY Change 13.11% -20.16%
% of Gross Profit 26.87% 22.36%
Operating Expenses $2.451M $2.970M
YoY Change -17.47% -14.26%
Operating Profit $117.0K -$242.0K
YoY Change -148.35% -125.64%
Interest Expense -$10.00K -$70.00K
YoY Change -85.71% -511.76%
% of Operating Profit -8.55%
Other Income/Expense, Net -$14.00K -$73.00K
YoY Change -80.82% -380.77%
Pretax Income $103.0K -$315.0K
YoY Change -132.7% -132.47%
Income Tax $20.00K -$156.0K
% Of Pretax Income 19.42%
Net Earnings $83.00K -$159.0K
YoY Change -152.2% -125.36%
Net Earnings / Revenue 1.45% -2.11%
Basic Earnings Per Share $0.01 -$0.03
Diluted Earnings Per Share $0.01 -$0.03
COMMON SHARES
Basic Shares Outstanding 5.537M 5.517M
Diluted Shares Outstanding 5.644M 5.517M

Balance Sheet

Concept 2021 Q1 2020 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.190M $5.330M
YoY Change -58.91% -25.35%
Cash & Equivalents $2.190M $5.331M
Short-Term Investments
Other Short-Term Assets $1.900M $1.890M
YoY Change 0.53% 57.5%
Inventory
Prepaid Expenses
Receivables $4.020M $3.558M
Other Receivables $2.520M $0.00
Total Short-Term Assets $10.63M $10.78M
YoY Change -1.4% -20.0%
LONG-TERM ASSETS
Property, Plant & Equipment $8.616M $10.89M
YoY Change -20.85% 13.91%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $882.0K $936.0K
YoY Change -5.77% 3.88%
Total Long-Term Assets $13.75M $14.43M
YoY Change -4.7% 19.71%
TOTAL ASSETS
Total Short-Term Assets $10.63M $10.78M
Total Long-Term Assets $13.75M $14.43M
Total Assets $24.38M $25.21M
YoY Change -3.29% -1.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.109M $1.234M
YoY Change -10.13% 226.46%
Accrued Expenses $1.567M $2.113M
YoY Change -25.84% -19.57%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $691.0K $680.0K
YoY Change 1.62% 63.46%
Total Short-Term Liabilities $4.330M $4.913M
YoY Change -11.87% 12.4%
LONG-TERM LIABILITIES
Long-Term Debt $3.270M $1.780M
YoY Change 83.71% 60.5%
Other Long-Term Liabilities $3.760M $2.210M
YoY Change 70.14% 240.0%
Total Long-Term Liabilities $3.270M $1.780M
YoY Change 83.71% 60.5%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.330M $4.913M
Total Long-Term Liabilities $3.270M $1.780M
Total Liabilities $11.57M $9.402M
YoY Change 23.04% 33.63%
SHAREHOLDERS EQUITY
Retained Earnings -$8.523M -$4.906M
YoY Change 73.73% 190.3%
Common Stock $33.05M $32.44M
YoY Change 1.87% 2.31%
Preferred Stock
YoY Change
Treasury Stock (at cost) $10.08M $10.08M
YoY Change 0.0% 0.0%
Treasury Stock Shares $668.0K $668.0K
Shareholders Equity $12.81M $15.81M
YoY Change
Total Liabilities & Shareholders Equity $24.38M $25.21M
YoY Change -3.29% -1.25%

Cashflow Statement

Concept 2021 Q1 2020 Q1
OPERATING ACTIVITIES
Net Income $83.00K -$159.0K
YoY Change -152.2% -125.36%
Depreciation, Depletion And Amortization $690.0K $610.0K
YoY Change 13.11% -20.16%
Cash From Operating Activities -$413.0K -$413.0K
YoY Change 0.0% -212.23%
INVESTING ACTIVITIES
Capital Expenditures $7.000K $401.0K
YoY Change -98.25% 1809.52%
Acquisitions
YoY Change
Other Investing Activities -$10.00K $7.000K
YoY Change -242.86% -143.75%
Cash From Investing Activities -$59.00K -$333.0K
YoY Change -82.28% 197.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$171.0K -1.162M
YoY Change -85.28% 6.12%
NET CHANGE
Cash From Operating Activities -$413.0K -413.0K
Cash From Investing Activities -$59.00K -333.0K
Cash From Financing Activities -$171.0K -1.162M
Net Change In Cash -$643.0K -1.952M
YoY Change -67.06% 132.66%
FREE CASH FLOW
Cash From Operating Activities -$413.0K -$413.0K
Capital Expenditures $7.000K $401.0K
Free Cash Flow -$420.0K -$814.0K
YoY Change -48.4% -334.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 pmd Depreciation And Amortization Excluding Rou Asset Amortization
DepreciationAndAmortizationExcludingRouAssetAmortization
687000
CY2020Q1 pmd Depreciation And Amortization Excluding Rou Asset Amortization
DepreciationAndAmortizationExcludingRouAssetAmortization
610000
CY2021Q1 pmd Income Tax Benefit Cares Act
IncomeTaxBenefitCARESAct
800000
CY2021Q1 pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-234000
CY2020Q1 pmd Increase Decrease In Accrued Expenses And Accrued Income Taxes
IncreaseDecreaseInAccruedExpensesAndAccruedIncomeTaxes
-1783000
CY2021Q1 pmd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-243000
CY2020Q1 pmd Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-238000
CY2021Q1 pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
171000
CY2020Q1 pmd Payments Of Equipment Financing
PaymentsOfEquipmentFinancing
169000
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
1109000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
577000
CY2021Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
4020000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
3356000
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1567000
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
1801000
CY2021Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
17609000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
16937000
CY2021Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1634000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1634000
CY2021Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
33020000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
32803000
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
217000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
163000
CY2021Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
217000
CY2020Q1 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
163000
CY2021Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
51
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
37
CY2021Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
568000
CY2021Q1 us-gaap Assets
Assets
24380000
CY2020Q4 us-gaap Assets
Assets
24003000
CY2021Q1 us-gaap Assets Current
AssetsCurrent
10627000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
9598000
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2190000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2833000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2833000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
7283000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2190000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
5331000
CY2021Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-643000
CY2020Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-1952000
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.18
CY2021Q1 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
CY2021Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2021Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5537000
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
5537000
CY2021Q1 us-gaap Common Stock Value
CommonStockValue
31000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
31000
CY2021Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
83000
CY2020Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-182000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.005
CY2021Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
50000000
CY2021Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6205000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
6205000
CY2021Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
3145000
CY2020Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
4809000
CY2021Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
211000
CY2020Q1 us-gaap Dividends Common Stock Cash
DividendsCommonStockCash
993000
CY2021Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2020Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.03
CY2021Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2020Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.03
CY2021Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
CY2020Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-44000
CY2021Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
CY2020Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-94000
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1529000
CY2020Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
1533000
CY2021Q1 us-gaap Gross Profit
GrossProfit
2568000
CY2020Q1 us-gaap Gross Profit
GrossProfit
2728000
CY2021Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
103000
CY2020Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-315000
CY2021Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
20000
CY2020Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-156000
CY2021Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
CY2020Q1 us-gaap Income Taxes Paid
IncomeTaxesPaid
169000
CY2021Q1 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2519000
CY2020Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
2495000
CY2021Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
525000
CY2020Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
570000
CY2021Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
664000
CY2020Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-222000
CY2021Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
CY2020Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
55000
CY2021Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
24000
CY2020Q1 us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
209000
CY2021Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
984000
CY2020Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-108000
CY2021Q1 us-gaap Interest Paid Net
InterestPaidNet
14000
CY2020Q1 us-gaap Interest Paid Net
InterestPaidNet
23000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
5163000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
1129000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
460000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
592000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
1034000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
1120000
CY2021Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
828000
CY2021Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
443000
CY2021Q1 us-gaap Liabilities
Liabilities
11568000
CY2020Q4 us-gaap Liabilities
Liabilities
11491000
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24380000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
24003000
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
4330000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3941000
CY2021Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
691000
CY2020Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
688000
CY2021Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3270000
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3444000
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-171000
CY2020Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-1162000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-59000
CY2020Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-333000
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-413000
CY2020Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-413000
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
83000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
-159000
CY2021Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
7000
CY2020Q1 us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
386000
CY2021Q1 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q1 us-gaap Operating Expenses
OperatingExpenses
2451000
CY2020Q1 us-gaap Operating Expenses
OperatingExpenses
2970000
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
117000
CY2020Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-242000
CY2021Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
268000
CY2020Q1 us-gaap Operating Lease Expense
OperatingLeaseExpense
306000
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
4720000
CY2021Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
963000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
875000
CY2021Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3757000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
3895000
CY2021Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
269000
CY2020Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
238000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4255000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
4286000
CY2021Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
224000
CY2020Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
264000
CY2021Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.039
CY2021Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P4Y292D
CY2021Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
882000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
888000
CY2021Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Before Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentBeforeTaxPortionAttributableToParent
-23000
CY2020Q1 us-gaap Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
-23000
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-14000
CY2020Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-73000
CY2021Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
CY2020Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
993000
CY2021Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
9000
CY2020Q1 us-gaap Payments To Acquire Other Productive Assets
PaymentsToAcquireOtherProductiveAssets
7000
CY2021Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
7000
CY2020Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
401000
CY2021Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
43000
CY2020Q1 us-gaap Payments To Develop Software
PaymentsToDevelopSoftware
65000
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.005
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
873000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1898000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
914000
CY2021Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
CY2020Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
140000
CY2021Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
8616000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
9231000
CY2021Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
280000
CY2020Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
331000
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8523000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-8606000
CY2021Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
5713000
CY2020Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
7537000
CY2021Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
193000
CY2020Q1 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2021Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
642000
CY2020Q1 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1106000
CY2021Q1 us-gaap Share Based Compensation
ShareBasedCompensation
217000
CY2020Q1 us-gaap Share Based Compensation
ShareBasedCompensation
163000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
424000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
14.55
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
29000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
604000
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
575000
CY2020Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.31
CY2021Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
14.26
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
3.47
CY2021Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
72000
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P6Y146D
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y
CY2021Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y292D
CY2021Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
12512000
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
12812000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
16820000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
15808000
CY2021Q1 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
CY2020Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
668000
CY2021Q1 us-gaap Treasury Stock Value
TreasuryStockValue
10082000
CY2020Q4 us-gaap Treasury Stock Value
TreasuryStockValue
10082000
CY2021Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
107000
CY2020Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
CY2021Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5644000
CY2020Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
5517000
CY2021Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5537000
CY2020Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5517000

Files In Submission

Name View Source Status
0001171843-21-003502-index-headers.html Edgar Link pending
0001171843-21-003502-index.html Edgar Link pending
0001171843-21-003502.txt Edgar Link pending
0001171843-21-003502-xbrl.zip Edgar Link pending
exh_311.htm Edgar Link pending
exh_312.htm Edgar Link pending
exh_321.htm Edgar Link pending
exh_322.htm Edgar Link pending
f10q_051321p.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
pmd-20210331.xml Edgar Link completed
pmd-20210331.xsd Edgar Link pending
pmd-20210331_cal.xml Edgar Link unprocessable
pmd-20210331_def.xml Edgar Link unprocessable
pmd-20210331_lab.xml Edgar Link unprocessable
pmd-20210331_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending